The authors reported an increased Firmicutes/Bacteroidetes ratio and Streptococcus abundance, with a reduction in Prevotella strains in patients with active MS when compared with healthy controls and patients with MS in remission (Cosorich et al., 2017)
Since BPC-157 has not undergone clinical testing in humans, there is no established dosing, no safety profile and no information on potential long-term risks
Temporary tenderness or a cool sensation at the IV site Rare brief lightheadedness as hydration is restored All treatments are performed in a calm, sterile, and comfortable setting with professional supervision with our infusion nurse at every step
Beyond the gut, FMT provides many improvements in the brain, including reversing cognitive decline, neuroprotective mechanisms by reducing alpha-synuclein accumulation, and restoring striatal levels of dopamine and serotonin (Hashish and Salama, 2023)
Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition
